How Fed. Circ. Guides PTAB On CBM Review: Part 1

By Brian Mudge and Andrew Kasnevich ( August 7, 2017, 1:57 PM EDT) -- We have previously written about the scope of patents eligible for covered business method review, including the Patent Trial and Appeal Board's inconsistent approaches in determining whether patents qualify for CBM review and the Federal circuit's narrowing of the eligibility standard employed by the PTAB.[1] On June 6, 2017, a divided Federal Circuit issued an order in Secure Axcess denying petitions for rehearing en banc.[2] By declining en banc rehearing, the Federal Circuit may have placed a stamp of finality on the scope of CBM review....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!